🕵️ DNA X, Inc. ($SONM)

SEC insider & ownership activity, last 12 months · CIK 1178697 · every row links its SEC filing

Insiders were quiet over the last 12 months – no open-market buys or sells. Jeffrey Wang trimmed 48.3% → 33.1%; AJP Holding Company, LLC trimmed 48.3% → 19.0%. One red-flag 8-K in the window: Delisting notice (3.01), May 20, 2026.

Insider flow

0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

HolderStakeClassScheduleEvent
Jeffrey Wang 33.1% 13DMar 20, 2025 filing ↗
Orbic North America, LLC. 33.1% 13DMar 20, 2025 filing ↗
Ashima Narula 33.1% 13DMar 20, 2025 filing ↗
Parveen Narula 33.1% 13DMar 20, 2025 filing ↗
DNA Holdings Venture Inc. 19.9% 13DDec 15, 2025 filing ↗
Scott Walker 19.9% 13DDec 15, 2025 filing ↗
Brock Pierce 19.9% 13DDec 15, 2025 filing ↗
Jeffrey Wang 19.0% 13DJun 26, 2025 filing ↗
Orbic North America, LLC. 19.0% 13DJun 26, 2025 filing ↗
Ashima Narula 19.0% 13DJun 26, 2025 filing ↗
Parveen Narula 19.0% 13DJun 26, 2025 filing ↗
AJP Holding Company, LLC 19.0% 13DJun 26, 2025 filing ↗
Laurence W. Lytton 8.1% 13GMay 15, 2026 filing ↗

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

ItemEvent date
Unregistered equity sale (3.02)Jun 29, 2026 filing ↗
Material Modifications to Rights of Security Holders (3.03)Jun 29, 2026 filing ↗
Charter/bylaw changes (5.03)Jun 29, 2026 filing ↗
Other events (8.01)Jun 29, 2026 filing ↗
Material agreement (1.01)Jun 29, 2026 filing ↗
Unregistered equity sale (3.02)Jun 29, 2026 filing ↗
Material Modifications to Rights of Security Holders (3.03)Jun 29, 2026 filing ↗
Charter/bylaw changes (5.03)Jun 29, 2026 filing ↗
Financial Statements and Exhibits (9.01)Jun 29, 2026 filing ↗
Agreement terminated (1.02)May 29, 2026 filing ↗
Financial Statements and Exhibits (9.01)May 29, 2026 filing ↗
Material agreement (1.01)May 20, 2026 filing ↗
New financial obligation (2.03)May 20, 2026 filing ↗
Delisting notice (3.01)May 20, 2026 filing ↗
Unregistered equity sale (3.02)May 20, 2026 filing ↗
Financial Statements and Exhibits (9.01)May 20, 2026 filing ↗
Earnings (2.02)May 20, 2026 filing ↗
Financial Statements and Exhibits (9.01)May 20, 2026 filing ↗
Auditor change (4.01)Apr 27, 2026 filing ↗
Financial Statements and Exhibits (9.01)Apr 27, 2026 filing ↗
Earnings (2.02)Apr 14, 2026 filing ↗
Financial Statements and Exhibits (9.01)Apr 14, 2026 filing ↗
Officer/director changes (5.02)Feb 9, 2026 filing ↗
Financial Statements and Exhibits (9.01)Feb 9, 2026 filing ↗
Officer/director changes (5.02)Jan 30, 2026 filing ↗
Financial Statements and Exhibits (9.01)Jan 30, 2026 filing ↗
Material agreement (1.01)Jan 23, 2026 filing ↗
Agreement terminated (1.02)Jan 23, 2026 filing ↗
Acquisition or disposition (2.01)Jan 23, 2026 filing ↗
Charter/bylaw changes (5.03)Jan 23, 2026 filing ↗